Skip to main content
. 2018 Sep 12;184(3-4):e127–e134. doi: 10.1093/milmed/usy235

TABLE IV.

Moderation Results for SM Treatment Utilization

B SE t p(CI95) Model R2
Main effects 0.091
 Constant 3.60 1.19 3.04 0.003 (1.25/5.95)
 Age −0.02 0.01 −1.51 0.133 (−0.05/0.01)
 Gender −0.53 0.36 −1.48 0.143 (−1.24/0.18)
 Pain intensity 0.09 0.11 0.88 0.383 (−0.12/0.30)
 Pain interference 0.01 0.04 0.20 0.841 (−0.07/0.09)
 Anxiety −0.01 0.04 −0.36 0.719 (−0.09/0.06)
 Depression 0.03 0.04 0.66 0.512 (−0.05/0.11)
 PTSD 0.01 0.02 0.40 0.690 (−0.03/0.04)
 Sleep 0.01 0.03 0.49 0.623 (−0.04/0.06)
Interaction effects R2
 Pain intensity × age 0.00 0.01 0.23 0.819 (−0.01/0.02) 0.000
 Pain intensity × gender −0.01 0.22 −0.06 0.953 (−0.45/0.43) 0.000
 Pain intensity × anxiety −0.01 0.01 −0.64 0.524 (−0.03/0.02) 0.004
 Pain intensity × depression −0.01 0.02 −0.95 0.342 (−0.04/0.02) 0.008
 Pain intensity × PTSD 0.00 0.01 0.06 0.956 (−0.01/0.01) 0.000
 Pain intensity × sleep 0.02 0.01 1.79 0.076 (0.00/0.05) 0.026
 Pain interference × age 0.00 0.00 0.24 0.810 (0.00/0.01) 0.001
 Pain interference × gender −0.03 0.07 −0.47 0.639 (−0.17/0.10) 0.002
 Pain interference × anxiety 0.00 0.00 0.72 0.474 (−0.01/0.01) 0.000
 Pain interference × depression 0.00 0.01 0.09 0.926 (−0.01/0.01) 0.000
 Pain interference × PTSD 0.00 0.00 0.77 0.440 (0.00/0.01) 0.001
 Pain interference × sleep 0.01 0.00 1.88 0.063 (0.00/0.02) 0.029

Note. R2 indicates the effect magnitude of the collective model with all covariates included. ∆R2 indicates the magnitude of the interaction effect.